接受激素治疗晚期前列腺癌患者血管炎症增强
本研究纳入32例接受激素治疗的晚期前列腺癌患者与17例年龄匹配、未接受激素治疗者,均行[18F]FDG-PET/CT评估动脉炎症。激素治疗组腹主动脉、升主动脉、胸降主动脉及全动脉汇总的TBRmax显著更高(均值1.6 vs 1.4,p<0.05),TBRmean在腹主动脉、升主动脉及全动脉汇总亦显著升高(p<0.05)。结论提示激素治疗与动脉炎症增加相关,可能解释该人群心血管风险升高。
要点
- 激素治疗组全动脉汇总TBRmax均值1.6,对照组1.4,差异显著(p<0.05)。
- 腹主动脉、升主动脉、胸降主动脉TBRmax及腹主动脉、升主动脉TBRmean均显著升高(p<0.05)。
- 两组年龄、BMI、总胆固醇、LDL、CRP及钙化斑块评分均无显著差异(p>0.05)。
核心结论
- 接受激素治疗的晚期前列腺癌患者在[18F]FDG-PET上显示动脉炎症较未接受激素治疗对照增加。
- 作者认为这些发现支持激素治疗与该人群心血管风险升高之间可能存在机制联系。
研究设计与样本
- 研究比较32例接受激素治疗的晚期前列腺癌患者与17例年龄匹配、影像前12个月内未接受激素治疗的前列腺癌患者。
- 所有参与者均接受[18F]FDG-PET/CT扫描。
- 在多个动脉节段及上腔静脉、脾脏、骨髓放置感兴趣区,以上腔静脉血池活性校正背景血管活性,计算各动脉节段靶本比(TBR)。
- 同时记录半定量钙化斑块(CP)评分。
主要发现
- 激素治疗组腹主动脉、升主动脉、胸降主动脉及全动脉汇总的TBRmax显著更高,全动脉汇总TBRmax均值1.6 vs 1.4(p<0.05)。
- 激素治疗组腹主动脉、升主动脉及全动脉汇总的TBRmean显著升高(p<0.05)。
- 两组年龄、BMI、总胆固醇、LDL、CRP及CP评分均无显著差异(p>0.05)。
关键数值与推荐
- 全动脉汇总TBRmax均值:激素治疗组1.6 vs 对照组1.4(p<0.05)。
- 腹主动脉、升主动脉、胸降主动脉TBRmax及腹主动脉、升主动脉、全动脉汇总TBRmean在激素治疗组显著升高(p<0.05)。
- 年龄、BMI、总胆固醇、LDL、CRP、CP评分组间比较均p>0.05。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: While blocking androgen production and action effectively slows prostate cancer (PCa) progression, it is associated with significant side effects, including an increased risk of cardiovascular disease. Inflammatory activity within atherosclerotic arteries can be assessed using [18F]FDG-PET imaging. Recently, [18F]FDG-PET has also gained relevance in PCa patients - alongside PSMA-targeted PET - for evaluating tumor aggressiveness. This study investigated the effect of hormone therapy on arterial inflammation in PCa patients using [18F]FDG-PET. METHODS: Thirty-two PCa patients receiving hormone therapy were compared to 17 age-matched PCa patients who had not undergone hormonal treatment in the 12 months prior to imaging. All participants underwent [18F]FDG-PET/CT scans. Regions of interest (ROIs) were placed across several arterial segments, as well as in the superior vena cava (SVC), spleen, and bone marrow. To account for background vascular activity, blood-pool activity in the SVC was used for correction, and target-to-background ratios (TBRs) were calculated for each arterial segment. A semi-quantitative calcified plaque (CP) score was also recorded. RESULTS: Patients receiving hormone therapy exhibited significantly higher TBRmax values in the abdominal aorta, ascending aorta, thoracic descending aorta, and in the combined analysis of all arteries (mean TBRmax: 1.6 vs. 1.4; all p < 0.05). Similarly, TBRmean values were significantly elevated in the abdominal and ascending aorta, as well as in the combined arterial analysis (all p < 0.05). No significant differences were observed between groups in age, BMI, total cholesterol, LDL, CRP, or CP scores (all p > 0.05). CONCLUSION: Advanced PCa patients undergoing hormone therapy demonstrate increased arterial inflammation on [18F]FDG-PET imaging compared to non-hormonally treated controls. These findings support a possible mechanistic link between hormone therapy and the elevated cardiovascular risk observed in this patient population.
引用
- Einspieler H, Muin D, Langrate IK, et al. Enhanced vascular inflammation in patients with advanced prostate cancer receiving hormone therapy. Eur J Nucl Med Mol Imaging. 2025. PMID: 40526128. doi:10.1007/s00259-025-07409-6
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。